Investor Resources
Robust IP Protection
Multiple issued & pending patents covering cell repair, ARS, viral inhibition, and food preservation.
Platform Technology
Synthetic surfactant chaperones that restore membrane integrity and prevent protein aggregation.
Commercial Versatility
Dual high-value therapeutic applications (in-vivo trauma) and industrial markets (food shelf-life).
Distinguished Leadership
Founded by MacArthur Fellow Dr. Raphael Lee with deep academic and biopharma industry experience.
Select Patents
Patent US-2024024354-A1
Methods for treating viral infections using amphiphilic block copolymers that target exposed hydrophobic viral domains to block replication, prevent tissue cell death, and promote cellular repair.
Patent US-9687502-B2
In vivo repair of damaged mammalian nerve tissue using targeted biomembrane fusion agents delivered via direct application or systemic parenteral administration.
Patent US-9572340-B2
Biocompatible multiblock copolymer surfactants engineered to catalyze protein refolding in aqueous solutions, restoring native conformation without altering protein composition across in vivo and in vitro stress conditions.
Publications Spotlight
Ischemia-Reperfusion
P188 Protects Against Ischemia-Reperfusion Injury In A Murine Hind-Limb Model
Neuroprotection
Amphiphilic, Tri-Block Copolymers Provide Potent, Membrane-Targeted Neuroprotection
Fixing A Hole (Cell Injury: Mechanisms, Responses, and Repair)
Maroon Biotech in the News
April 29, 2022 | UChicago News
March 7, 2022 | The University of Chicago Polsky Center for Entrepreneurship and Innovation
October 17, 2017 | Page Ivey, University of South Carolina
February 2006 | Lydialyle Gibson, University of Chicago Magazine
